扶桑薬品工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証PRM | 医薬品 | 4538/E00953 | Fuso Pharmaceutical Industries, Ltd. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2016/12/30 | 日証協 | 34,900株 | -0.85% | 600株 | -14.29% | 35,257株 | -6.62% | 1,300株 | -43.48% |
2016/12/22 | 日証協 | 35,200株 | +1.15% | 700株 | -92.13% | 37,757株 | 0% | 2,300株 | +91.67% |
2016/12/16 | 日証協 | 34,800株 | +14.47% | 8,900株 | +9.88% | 37,757株 | +1.89% | 1,200株 | -7.98% |
2016/12/09 | 日証協 | 30,400株 | +5.19% | 8,100株 | +440% | 37,057株 | 0% | 1,304株 | +8.67% |
2016/12/02 | 日証協 | 28,900株 | -22.73% | 1,500株 | -88.37% | 37,057株 | -2.37% | 1,200株 | -81.82% |
2016/11/25 | 日証協 | 37,400株 | +8.09% | 12,900株 | +152.94% | 37,955株 | -6.18% | 6,602株 | +312.62% |
2016/11/18 | 日証協 | 34,600株 | +9.49% | 5,100株 | -20.31% | 40,455株 | -0.5% | 1,600株 | +23.08% |
2016/11/11 | 日証協 | 31,600株 | +6.4% | 6,400株 | -18.99% | 40,658株 | +0.49% | 1,300株 | -76.42% |
2016/11/04 | 日証協 | 29,700株 | +4.21% | 7,900株 | -13.19% | 40,458株 | +11.63% | 5,514株 | +5359.41% |
2016/10/28 | 日証協 | 28,500株 | -4.04% | 9,100株 | +145.95% | 36,243株 | -5.72% | 101株 | -83.17% |
2016/10/21 | 日証協 | 29,700株 | -34.87% | 3,700株 | -73.19% | 38,443株 | -18.97% | 600株 | -60% |
2016/10/14 | 日証協 | 45,601株 | -26.92% | 13,800株 | -82.97% | 47,444株 | -25.57% | 1,500株 | -97.15% |
2016/10/07 | 日証協 | 62,399株 | -64.76% | 81,015株 | +151.6% | 63,743株 | -70.1% | 52,659株 | +39.68% |
2016/09/30 | 日証協 | 177,058株 | -24.39% | 32,200株 | +69.47% | 213,158株 | -43.7% | 37,700株 | +34.64% |
2016/09/23 | 日証協 | 234,176株 | +4% | 19,000株 | +387.8% | 378,619株 | +3.84% | 28,000株 | -73.31% |
2016/09/16 | 日証協 | 225,176株 | +53.93% | 3,895株 | -97.2% | 364,610株 | +21.29% | 104,904株 | +12.93% |
2016/09/09 | 日証協 | 146,281株 | -6.34% | 139,123株 | +603% | 300,610株 | -0.33% | 92,895株 | +245.4% |
2016/09/02 | 日証協 | 156,176株 | +2.56% | 19,790株 | -1.05% | 301,610株 | -0.98% | 26,895株 | +364.43% |
2016/08/26 | 日証協 | 152,281株 | +9.42% | 20,000株 | +1900% | 304,610株 | +0.99% | 5,791株 | +189.55% |
※株式分割は考慮していませんのでご注意ください。